7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Symptoms Explained

The Four Stages of COPD: Symptoms at Each Stage and What Treatment Changes

22 min read
The Four Stages of COPD: Symptoms at Each Stage and What Treatment Changes

Key Takeaways

  • COPD stages are defined by FEV1 on spirometry: 80% or more of predicted is mild, 50–79% moderate, 30–49% severe, and below 30% very severe.
  • A diagnosis requires an FEV1/FVC ratio below 0.70 after an inhaled airway-opening medicine, which shows the obstruction is fixed rather than temporary.
  • Current guidelines pair the spirometry grade with a symptom score and flare-up history, because two people at the same stage can need very different treatment.
  • Each serious exacerbation can leave lung function slightly lower than before, which is why preventing flare-ups is a central goal from stage 3 onward.
  • Long-term oxygen therapy is prescribed on the basis of blood oxygen tests, not breathlessness, and needs to be used at least 16 hours a day to protect the heart.
  • Quitting smoking is the only step shown to change the rate of lung function decline, and its benefit applies at every stage, including stage 4.
Quick Answer

COPD is commonly divided into four stages, or grades, based on a breathing test called spirometry. Stage 1 (mild) means lung function is 80% or more of predicted; stage 2 (moderate) is 50–79%; stage 3 (severe) is 30–49%; stage 4 (very severe) is below 30%. Symptoms, flare-up history and other health problems matter as much as the number, and treatment is adjusted to all of them rather than the stage alone.

The first sign is often the stairs. Not a dramatic collapse, just a quiet decision to take the elevator at work, or to pause on the landing and pretend to check a phone. Years can pass this way, with a morning cough written off as a habit and breathlessness blamed on age or an extra ten pounds, before anyone blows into a spirometer and hears the word COPD.

Once that word arrives, the next question is almost always the same: how bad is it? Doctors answer with a stage, and the internet answers with a life expectancy, and neither answer alone is honest enough. The four stages describe airflow, not destiny. Two people with identical test results can live very differently, depending on whether they still smoke, how often they get flare-ups, and how fit their heart and legs are.

This guide walks through what each stage feels like, what actually changes in care from one to the next, and what the evidence says about the questions people are often afraid to ask out loud.

What are the 4 stages of COPD?

Chronic obstructive pulmonary disease is an umbrella term for long-term lung damage, most often from smoking, that narrows the airways and makes it hard to push air out. The staging system most clinicians use comes from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and is built on one number: FEV1, the volume of air you can force out in the first second of a hard exhale, expressed as a percentage of what would be expected for someone of your age, sex, height and ethnicity.

Stage GOLD grade FEV1 (% of predicted) What it usually feels like
Stage 1 Mild 80% or higher Cough, some mucus, little or no breathlessness
Stage 2 Moderate 50% to 79% Short of breath on hills, stairs or hurrying
Stage 3 Severe 30% to 49% Breathless with everyday tasks; flare-ups more frequent
Stage 4 Very severe Below 30% Breathless at rest or with minimal effort; oxygen levels may fall

Those thresholds are the ones described by the Cleveland Clinic and used in mainstream guidance. Before the percentage even matters, the diagnosis itself requires a ratio: the amount you exhale in one second divided by the total you can exhale must be below 0.70 after an inhaled airway-opening medicine, confirming the obstruction is fixed rather than temporary.

One caution worth stating early. The word stage suggests a staircase that everyone climbs at the same pace, which is simply not true. Many people diagnosed at stage 1 or 2 never reach stage 4, particularly if they stop smoking. The grade tells you how much airflow has been lost so far; it says nothing about how fast, or whether, more will follow.

How do you tell what stage of COPD you are in?

You cannot judge your stage from symptoms alone, and neither can your doctor. The only way to know is spirometry, a test that takes about 15 minutes and involves blowing as hard and long as you can into a tube connected to a small machine. The NHS describes it as one of the standard tests for confirming COPD and gauging its severity.

Here is what happens. A technician or nurse fits a clip on your nose so all the air leaves through your mouth. You breathe in fully, seal your lips around the mouthpiece, then blast the air out until your lungs feel empty, usually for at least six seconds. You repeat this three times or more so the best effort can be recorded. Then you inhale a quick-acting airway-relaxing medicine, wait around 15 minutes, and do it again. The second set of blows is the one that counts for staging.

The machine compares your FEV1 with the predicted value for your demographics. If you blow out 55% of what is expected, you are graded moderate; at 42%, severe. The number can shift by a few percentage points from one visit to the next depending on effort, a recent chest infection or the time of day, so clinicians look at the trend over years rather than a single reading.

If you have been told you have COPD but have never done this test, it is a fair question to ask. A stethoscope, a chest X-ray or a description of your cough can raise suspicion, but none of them can assign a stage. The Mayo Clinic lists spirometry as the most common lung function test used for exactly this purpose.

Why your stage number doesn't tell the whole story

Around 2011 the GOLD guideline authors did something unusual: they admitted the four-stage ladder was not predicting enough on its own. Two people at stage 2 could have wildly different lives. One might be a retired carpenter who walks two miles a day and has never been hospitalized. The other might be housebound after three flare-ups in a winter. Same FEV1, different diseases in practice.

So the framework now runs on two tracks. The spirometry grade (1 through 4) still records lung function. Alongside it, patients are sorted into groups, currently labeled A, B and E, using two things that are measured in the clinic rather than in a machine. The first is how symptomatic you are, captured by short questionnaires that ask about cough, phlegm, chest tightness and how far you can walk before stopping. The second is your history of exacerbations, the medical term for flare-ups, over the past year, and whether any of them put you in hospital.

The E group, for people with frequent or severe flare-ups, is where treatment intensifies fastest, regardless of grade. That reflects hard-won evidence: each serious exacerbation tends to leave lung function a little lower than before, and recovery gets slower with each one.

Why does this matter to you as a patient? Because your appointment should include more than a printout of a percentage. Expect to be asked how many chest infections you have had, how breathless you are dressing or walking to the mailbox, and whether your sleep or mood has changed. Those answers steer your care as much as the spirometry does, and they are the things you have the most power to influence.

Stage 1 COPD: the symptoms most people dismiss

Mild COPD is the stage almost nobody is diagnosed at, because it rarely announces itself. Lung function is still 80% or more of predicted, and the body compensates well. The typical picture, according to MedlinePlus, is a cough that lingers, some mucus, particularly in the morning, and maybe a wheeze when you catch a cold.

The trouble is that these symptoms get filed under other headings. A smoker’s cough. Allergies. Getting older. People at this stage often feel fine on flat ground and only notice something on a steep hill or a cold morning, and even then the explanation is usually fitness rather than lungs.

What is happening inside is more consequential than it feels. The lining of the small airways is inflamed and producing extra mucus. The tiny hair-like cilia that normally sweep debris upward are damaged, so mucus pools and needs to be coughed out. In the air sacs, some walls have already broken down, merging small sacs into larger, less efficient ones. None of this is yet enough to restrict daily life, which is exactly why it gets ignored.

The single most important thing about stage 1 is that it is the best moment to act. Stopping smoking at this point does not restore lost function, but the NHS is clear that it slows further decline more than any other step available. A diagnosis here also means a baseline reading exists, so future tests can show whether the disease is stable or moving.

Treatment at this stage is usually light: a quick-acting inhaled medicine to open the airways when needed, guidance on quitting smoking, and encouragement to stay physically active. The prescribing clinician decides what fits your circumstances.

Stage 2 COPD: when breathlessness starts changing your habits

Moderate COPD, with lung function between 50% and 79% of predicted, is where most diagnoses actually happen. The reason is simple: this is the stage at which breathlessness becomes hard to explain away. Carrying groceries upstairs, keeping pace with a friend on a walk, or hurrying for a bus now produces a distinct air hunger that takes a minute or two to settle.

People often respond by quietly shrinking their world. They stop taking the stairs, decline the hike, park closer. This feels like coping, and in a narrow sense it is, but it sets up a trap: less movement leads to weaker leg muscles, and weaker muscles demand more oxygen for the same task, which makes breathlessness worse. Clinicians call this the deconditioning spiral, and breaking it is one of the central goals of treatment at this stage.

Symptoms beyond breathlessness tend to become daily rather than occasional. The Mayo Clinic lists a chronic cough that may bring up clear, white, yellow or greenish mucus, wheezing, chest tightness and frequent respiratory infections. Fatigue is common and often underestimated; simply breathing costs more energy when air has to be forced through narrowed tubes.

Treatment usually steps up here. A longer-acting inhaled medicine that keeps airway muscles relaxed for 12 to 24 hours is commonly added, so the airways stay open through the day rather than only after a rescue puff. Pulmonary rehabilitation, a supervised program of exercise and education that the NHS describes as typically lasting around six weeks with sessions twice a week, becomes appropriate for many people, and the evidence for it improving walking distance and quality of life is among the strongest in the whole field.

Stage 3 COPD: flare-ups and what they do to your lungs

Severe COPD means FEV1 has dropped to between 30% and 49% of predicted, and the defining feature of this stage is usually not the daily breathlessness, though that is real, but the flare-ups. An exacerbation is a sudden worsening, typically triggered by a viral or bacterial chest infection or by air pollution, in which breathing gets sharply harder, mucus increases or changes color, and the usual inhaler no longer seems to work.

Each one matters. During a flare-up, the airways swell and fill with secretions; oxygen levels can fall and carbon dioxide can build up. Recovery takes days to weeks, and the evidence summarized by the Cleveland Clinic and others is that lung function often does not return fully to its pre-flare baseline. Frequent exacerbations therefore accelerate the disease and are the leading reason people with COPD end up in hospital.

Day to day, someone at stage 3 is usually breathless dressing, showering or walking around the house. Sleep may be disturbed. Weight can drift in either direction: some people lose muscle because breathing burns so many calories and eating feels like effort, while others gain weight from inactivity. Anxiety and low mood become common, partly because breathlessness itself is frightening and partly because life has narrowed.

Care changes in a few concrete ways. Inhaled anti-inflammatory medicine may be added for people with repeated flare-ups, aiming to calm the airway lining and reduce how often exacerbations happen. Many patients are given a written action plan and a standby supply of medicines to start at the first sign of a flare-up, with instructions on when to call. Pulmonary rehabilitation remains valuable. Blood oxygen is checked more regularly, since this is the stage at which it may start to dip.

Stage 4 COPD: what very severe disease means for daily life

Very severe COPD is defined by an FEV1 below 30% of predicted. At this level, breathlessness is present with minimal exertion and sometimes at rest, and the lungs may no longer keep blood oxygen at a healthy level. The NHS and Cleveland Clinic both describe this stage as one where quality of life is significantly affected and flare-ups can become life-threatening.

Several things can happen in the body that were not part of earlier stages. Low oxygen over months puts strain on the right side of the heart, which has to pump blood through stiffened lung vessels; this can lead to fluid retention, noticeable as swollen ankles. Carbon dioxide may accumulate, causing morning headaches and daytime drowsiness. Muscle wasting becomes more common, and weight loss at this stage is taken seriously because it is linked to worse outcomes.

Treatment at stage 4 is about supporting the body’s oxygen supply and preventing crises. Long-term oxygen therapy is considered when blood oxygen is persistently low; the NHS notes it needs to be used for at least 16 hours a day to help, because the benefit comes from protecting the heart and organs over time rather than from relief in the moment. It is prescribed on the basis of blood tests, not on how breathless a person feels, and it does not help everyone at this stage.

For a minority of carefully selected patients, surgical options exist: removing the most damaged sections of lung so the healthier parts can expand, placing one-way valves through a bronchoscope to achieve a similar effect, or lung transplantation. Each has real risks, strict eligibility criteria and long assessment processes, and whether any is appropriate is a decision for the specialist team.

How treatment changes from stage 1 to stage 4

It helps to think of COPD treatment as layers added rather than swapped. The foundation is the same at every stage and never comes off: stop smoking, stay active, avoid lung irritants, and manage other conditions such as heart disease that share the same risk factors. What changes is how much medical scaffolding gets built on top.

Inhaled medicines fall into two mechanical families. Bronchodilators relax the smooth muscle wrapped around the airways so the tubes widen; short-acting versions work within minutes and last a few hours, long-acting versions hold the airways open for half a day to a full day. Anti-inflammatory inhalers work differently, dampening the swelling and immune activity in the airway lining, and are usually reserved for people with frequent flare-ups because they carry a modestly higher risk of chest infections. Choosing among these, and deciding when to combine them, is the prescribing clinician’s job and depends on your symptoms and exacerbation history more than your grade.

Pulmonary rehabilitation is the most underused tool at every stage from moderate onward. It is not a gym class for the lungs so much as a retraining of the whole body: supervised walking and strength work, breathing techniques, education about medicines and nutrition, and, quietly, a group of people who understand. The Cleveland Clinic and NHS both highlight it as a core treatment.

Oxygen and surgery belong to the later stages and are governed by test results and eligibility criteria rather than by how a person feels. Palliative care, which is about symptom relief rather than end of life, can be introduced at any point where breathlessness or anxiety is hard to control, and earlier is generally better than later.

How long does it take to go from stage 1 to stage 4 COPD?

There is no honest single answer, and anyone giving you one in years is guessing. COPD progresses at very different speeds in different people, and a meaningful share of those diagnosed at mild or moderate grades stay there for the rest of their lives.

What the evidence does support is a list of things that speed the decline and things that slow it. The biggest accelerator by far is continued smoking. Everyone’s lung function falls gradually with age after about the late twenties, but in people who keep smoking with COPD the yearly loss is markedly steeper, and the NHS and Mayo Clinic are unambiguous that quitting is the intervention with the clearest effect on the trajectory. The rate of loss tends to slow toward a more normal pace within a year or two of stopping, though the damage already done does not reverse.

Frequent exacerbations are the second accelerator. Each significant flare-up can knock lung function down a notch that is not fully recovered, so someone with three hospitalizations in a year is on a different curve from someone with none. Ongoing exposure to occupational dust, fumes or heavy indoor air pollution also matters, as does an inherited deficiency of a protective protein called alpha-1 antitrypsin, which can drive rapid progression in younger people and is worth testing for if COPD appears before age 45 or without a smoking history.

On the other side of the ledger sit regular physical activity, treatment adherence, keeping weight in a healthy range and reducing exposure to respiratory infections. None of these guarantees stability. Together, though, they are the reason the question of how long is unanswerable in the abstract and more encouraging in the specific.

What is the life expectancy for someone with stage 4 COPD?

This is the question people type into search engines at two in the morning, and the pages that answer it with a tidy number are not being straight with you. Survival statistics for COPD stages exist in research papers, but they describe averages across large groups, many of them older studies from before current treatments, and they cannot be applied to an individual with any precision. Reputable sources such as the NHS deliberately avoid quoting them, and this article will follow that lead.

What the research does agree on is which factors carry weight. Lung function is one, and it is a meaningful one, but it is far from the only one. Prognostic tools used in clinics combine FEV1 with body weight, how breathless a person is during ordinary activities, and how far they can walk in six minutes; that combination predicts outcomes considerably better than FEV1 alone. Frequent hospitalizations for flare-ups, persistently low blood oxygen, heart disease and unintended weight loss each independently point toward a harder road.

Notice what is on that list: things that can change. A person at stage 4 who completes pulmonary rehabilitation, stops smoking, uses prescribed oxygen as directed and avoids two flare-ups over a winter has moved their own odds even though their spirometry grade has not changed.

The WHO reports that COPD caused about 3.5 million deaths worldwide in 2021, making it the third leading cause of death globally, so nobody should pretend this is a benign condition. The honest framing is this: stage 4 is serious, the future is uncertain, and much of what shapes that future is still within reach.

What are the final stages of COPD before death?

Families ask this quietly, often in a hallway, and it deserves a clear, calm answer. End-stage COPD is not a spirometry grade; it is a clinical picture. It typically involves breathlessness that is present at rest despite full treatment, oxygen levels that stay low even with supplemental oxygen, flare-ups that come closer together and recover less completely, marked weight and muscle loss, and increasing time spent in bed or a chair. Confusion or drowsiness can develop when carbon dioxide builds up.

The pattern is rarely a smooth downhill line. More often it is a series of steps: a hospital admission, partial recovery to a slightly lower plateau, a period of relative stability, then another step. This unpredictability is one reason COPD has historically been underserved by palliative care compared with cancer, where the timeline is often clearer. It is also why planning conversations are best had early, while a person is well enough to say what matters to them.

Palliative care in COPD focuses on the sensation of breathlessness itself, which can be eased with several approaches: positioning, a handheld fan directed at the face, breathing techniques, treatment of anxiety, and medicines chosen by the specialist team to reduce the feeling of air hunger. Good palliative care is not the same as stopping treatment; people often continue their inhalers and oxygen alongside it.

Advance care planning covers practical questions. Would you want to be placed on a ventilator during a severe flare-up? Where would you prefer to be cared for? Who speaks for you if you cannot? Writing these down while breathing is manageable spares loved ones from guessing later and, in the experience of clinicians who do this work, tends to bring relief rather than distress.

What you can do at any stage to slow COPD down

If there is one opinion this article will stand behind, it is that the stage you are at matters less than what you do next. The evidence-supported list is short, and none of it requires a prescription.

Stopping smoking sits first because nothing else comes close. The NHS states plainly that quitting is the most effective way to slow the damage. It is hard, it often takes several attempts, and support from a clinician roughly doubles the odds of success compared with willpower alone. If you have quit already, avoiding secondhand smoke, wood smoke and workplace dust or fumes is the next layer of protection.

Movement is second. Breathlessness makes people want to rest, but rest weakens the muscles that make breathing feel easier. Walking, stationary cycling, light weights and even seated exercises all count. Pulmonary rehabilitation is the structured version of this and is worth asking for by name at any stage from moderate onward.

Preventing infections is third. Chest infections trigger most flare-ups, so hand washing, avoiding close contact with people who are unwell during winter, and asking your care team about protection against seasonal respiratory illness are all practical steps.

Eating well rounds it out. Underweight people with COPD do worse, and so do people carrying significant extra weight around the abdomen, which pushes up on the diaphragm. Small, frequent, protein-rich meals help those who tire while eating. A dietitian referral is reasonable if weight is drifting.

Knowing your action plan ties everything together: recognizing the early signs of a flare-up and acting on them in the first 24 to 48 hours is consistently associated with shorter, milder episodes.

When to see a doctor about COPD symptoms

Some symptoms warrant an appointment; others warrant a phone call today or emergency care now. Knowing which is which is part of living well with this condition.

Book a routine appointment if you have a cough lasting more than three weeks, are getting more breathless than you were six months ago, notice more mucus than usual, or have had two or more chest infections in a year. Anyone over 35 with a history of smoking and any of these symptoms should ask specifically about spirometry, since MedlinePlus and the NHS both note that COPD is frequently undiagnosed until it is moderate or worse.

Call your care team promptly, ideally the same day, if you already have COPD and your breathlessness worsens over a day or two, your mucus turns yellow, green or brown, you develop a fever, or your usual reliever inhaler is needed far more often than normal. These are early flare-up signs, and the earlier treatment starts, the shorter the episode tends to be.

Seek emergency care immediately, by calling emergency services, for any of the following red flags: severe breathlessness that does not ease with your rescue medicine or makes it impossible to finish a sentence; blue or gray lips, face or fingernails; chest pain; new confusion, extreme drowsiness or difficulty waking; a racing or irregular heartbeat with breathlessness; or coughing up blood. Do not drive yourself.

Between those extremes, trust your own pattern. People who live with COPD usually know their normal, and a change from that normal is reason enough to pick up the phone.

Frequently asked questions

How do you tell what stage of COPD you are in?

Only a spirometry test can determine your COPD stage. You blow as hard as possible into a device that measures how much air you exhale in one second (FEV1), repeated after an inhaled airway-opening medicine. That result is compared with the predicted value for your age, sex and height. Symptoms alone cannot assign a stage, because breathlessness and cough vary widely between people with the same lung function.

What is the life expectancy for someone with stage 4 COPD?

No reliable individual figure exists, and mainstream sources such as the NHS avoid quoting one. Stage 4 is serious, but outlook depends on far more than lung function: body weight, how far you can walk, how often you have flare-ups, blood oxygen levels, heart health and whether you still smoke all carry weight. Several of these can improve with treatment and lifestyle changes, even when the spirometry grade does not.

How long does it take to go from stage 1 to stage 4 COPD?

It varies from several years to never. Many people diagnosed at mild or moderate stages remain there for life, especially after quitting smoking. Progression is fastest in people who continue to smoke, have frequent flare-ups, are exposed to workplace dust or fumes, or have an inherited alpha-1 antitrypsin deficiency. Lung function falls slowly with age in everyone, but the steep decline seen in COPD is largely driven by these modifiable factors.

What are the final stages of COPD before death?

End-stage COPD is a clinical picture rather than a test result. It usually involves breathlessness at rest despite full treatment, low oxygen levels even on supplemental oxygen, flare-ups that come closer together, marked weight and muscle loss, and increasing time confined to bed or a chair. Confusion or drowsiness may develop as carbon dioxide builds up. Palliative care can ease breathlessness considerably during this phase and is best introduced early.

Can COPD be reversed or go back a stage?

The structural lung damage in COPD does not reverse, and lost lung function is not regained. Test results can fluctuate by a few percentage points depending on effort, recent infections or how well symptoms are controlled, so a reading may occasionally move across a stage boundary. What genuinely changes is the rate of further decline, which slows substantially after quitting smoking, and the severity of symptoms, which often improves with pulmonary rehabilitation.

What is the difference between COPD stages and GOLD groups A, B and E?

Stages 1 to 4 describe lung function measured by spirometry. Groups A, B and E describe how the disease behaves: A means few symptoms and few flare-ups, B means more symptoms but few flare-ups, and E means frequent or severe exacerbations regardless of symptom level. Treatment decisions, particularly about adding inhaled anti-inflammatory medicine, are guided mainly by the group rather than the stage.

Do you need oxygen at stage 3 COPD?

Not necessarily. Oxygen therapy is prescribed based on blood oxygen measurements, not on the stage or on how breathless someone feels. Many people at stage 3 maintain adequate oxygen levels and do not need it, while some are found to have persistently low levels and benefit. When prescribed for long-term use, oxygen must be worn for at least 16 hours a day to protect the heart and other organs over time.

What does a COPD flare-up feel like?

A flare-up, or exacerbation, is a sudden worsening over hours or days: noticeably harder breathing, more coughing, increased mucus that may turn yellow, green or brown, chest tightness and often fatigue or a fever. The usual reliever inhaler seems less effective. Most are triggered by chest infections or air pollution. Acting within the first day or two, following a written action plan, is linked to shorter and milder episodes.

Is pulmonary rehabilitation worth it for COPD?

Yes; it is among the best-supported treatments for COPD from the moderate stage onward. A typical program runs around six weeks with two supervised sessions a week, combining exercise training, breathing techniques and education about medicines, nutrition and managing flare-ups. Evidence consistently shows improvements in walking distance, breathlessness and quality of life, and fewer hospital admissions. It is suitable at stage 4 too, with exercises adapted to ability.

Can you have COPD if you have never smoked?

Yes. Smoking is the leading cause, but the WHO notes that long-term exposure to indoor air pollution from cooking or heating fuels, occupational dusts and chemical fumes, outdoor air pollution and an inherited deficiency of the protective protein alpha-1 antitrypsin can all cause COPD. Poor lung growth in childhood from infections or premature birth also raises risk. Anyone with a persistent cough and breathlessness deserves spirometry regardless of smoking history.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published October 17, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.